USPTO US Appeals Court Upholds Invalidation of Columbia University Sequencing Chemistry Patents The appellate court's decision deals a blow to a 2017 Columbia University lawsuit that alleged Illumina infringed one of the invalidated patents. Rakuten Medical Sues Illumina Over Trademark Dispute The cancer therapy developer has asked a US federal court to declare that its Illuminox platform does not infringe Illumina's trademarks. USPTO Board Denies Illumina Request to Review BGI Patent Illumina had argued that Complete Genomics' patent covering two-color sequencing-by-synthesis chemistry was obvious, but the US PTAB disagreed. CRISPR Patent Fight Turns Ugly as UC Accuses Broad Researchers of Lying About Claims The Broad Institute called UC's new legal strategy "deeply unfortunate" and called on the university to "move beyond litigation." CRISPR Patent Pools Pop Up, But Participation Uncertain as IP Holders Continue Legal Battles Premium As MPEG LA tries to complete its larger CRISPR IP patent pool, smaller license agreements continue and a mini-pool has emerged between key players. Jun 25, 2019 CRISPR Patent Fight Between UC Berkeley, Broad Flares Up as USPTO Initiates New Interference Jun 14, 2019 USPTO Denies Foundation Medicine Attempt to Invalidate Guardant Health Patent Jul 18, 2018 Inscripta Confirms CRISPR-MAD7 Editing Activity in Mammalian Cells, Releases New MAD2 Enzyme Premium Jan 17, 2018 Rockefeller, Broad Settle CRISPR IP Dispute; EPO Denies Broad European Patent Oct 28, 2016 CRISPR Patent Interference Likely Heads to Oral Arguments Over Preliminary Motions Premium Jun 1, 2016 Illumina Sues Qiagen for Patent Infringement Oct 9, 2015 USPTO Report to Congress Says No Immediate Action Necessary on Confirmatory Genetic Testing Nov 6, 2014 IP Update: Recent Patents Awarded to Alnylam Pharmaceuticals, Marina Biotech, and More Premium Oct 30, 2014 IP Update: Recent Patents Awarded to SomaGenics, Pioneer Hi-Bred, and More Premium Oct 29, 2014 USPTO Appeals Board Invalidates Claims on Illumina Patent Included in Qiagen-IBS Litigation Oct 16, 2014 IP Update: Recent Patents Awarded to Alnylam, Quark, Qiagen, and More Premium Sep 25, 2014 IP Update: Recent Patents Awarded to Alnylam, GE Healthcare, Sanofi, and More Premium Aug 27, 2014 Legal Experts Assess Potential Impact of GeneDx's IPR Challenge of Myriad Patents Premium Aug 19, 2014 GeneDx Files IPR Petitions at USPTO against 11 Patents at Issue in Myriad Lawsuit Aug 14, 2014 IP Update: Recent Patents Awarded to Alnylam, Tekmira, Polyplus, and More Premium Aug 7, 2014 IP Update: Recent Patents Awarded to Alnylam, RXi, IBM, and More Premium Jul 31, 2014 IP Update: Recent Patents Awarded to City of Hope, Alnylam, and More Premium Jul 3, 2014 IP Update: Recent Patents Awarded to Quark, Regulus, Alnylam, and More Premium Jun 5, 2014 IP Update: Recent Patents Awarded to Alnylam, Life Tech, and More Premium May 29, 2014 IP Update: Recent Patents Awarded to Silence Therapeutics, UMass, and More Premium Load More Breaking News BTIG Initiates Coverage of Berkeley Lights With Buy Rating Quest Diagnostics to Offer Biocept's Target Selector NGS Lung Cancer Test Novacyt 2020 Revenues Surge on Strong Demand for SARS-CoV-2 Testing Products Leidos Wins CDC Bioinformatics Contract Worth up to $13M Thermo Fisher Scientific Next-Generation SARS-CoV-2 PCR Test Nabs CE-IVD Mark Cytosine Base Editor Enables Genome-Wide Genetic Function Screening The Scan Renewed Gain-of-Function Worries The New York Times writes that the pandemic is renewing concerns about gain-of-function research. Who's Getting the Patents? A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports. Other Uses CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2. PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.